VPAC1 receptor modulation of microglial phenotype to support hippocampal neurogenesis may therefore be of therapeutic relevance to conditions combining cognitive decline and neuro-inflammation such as temporal lobe epilepsy, Alzheimer's, and other neurodegenerative diseases. Here, VIPR1 is linked to temporal lobe epilepsy.